Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19

Samaneh Pourajam1 Department of Internal Medicine, School of MedicineIsfahan University of Medical SciencesIsfahanIran

Azam Zafarbakhsh2 Department of Obstetrics and Gynecology, School of MedicineIsfahan University of Medical SciencesIsfahanIran

Majid Hosseinzadeh3 Department of Genetics and Molecular Biology, School of MedicineIsfahan University of Medical SciencesIsfahanIran

Mohammad Shirzadi1 Department of Internal Medicine, School of MedicineIsfahan University of Medical SciencesIsfahanIran

Mansour Siavash4 Isfahan Endocrine and Metabolism Research CenterIsfahan University of Medical SciencesIsfahanIran

Hamid Solgi4 Isfahan Endocrine and Metabolism Research CenterIsfahan University of Medical SciencesIsfahanIran;5 Division of Clinical Microbiology, Department of Laboratory Medicine, Amin HospitalIsfahan University of Medical SciencesIsfahanIranCorrespondence[email protected]

Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date